Peripheral artery disease (PAD) is a progressive atherosclerotic disease characterized by the accumulation of plaque within the peripheral arteries, resulting in arterial stenosis or occlusion and reduced blood flow to the lower extremities. Patients with significant PAD may experience symptoms such as intermittent claudication, ischemic rest pain, or critical limb-threatening ischemia (CLTI).
For patients requiring endovascular intervention, Zylox-Tonbridge offers a comprehensive portfolio of peripheral vascular stents and balloon catheter systems designed to restore vessel patency, improve blood perfusion, and support long-term clinical outcomes. Our solutions are engineered to provide optimal deliverability, vessel scaffolding, and durable patency across a wide range of peripheral arterial lesions.
As one of leading peripheral vascular device companies, Zylox-Tonbridge offers CE-marked peripheral artery intervention devices including peripheral stents and gateway PTA balloon catheter with a broad range of sizes. Zylox owns proprietary drug coating technology, which ensures the effective paclitaxel crystallization control and uniform, dense and stable drug coating of the products.
Providing Comprehensive Solutions for Patients Worldwide
Stay informed with the latest company news from Zylox-Tonbridge.